Search Results - "Villaseca, J"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper by Zozaya, N, Villaseca, J, Abdalla, F, Ancochea, A, Málaga, I, Trapero-Bertran, M, Martín-Sobrino, N, Delgado, O, Ferré, P, Hidalgo-Vega, A

    Published in Orphanet journal of rare diseases (24-02-2023)
    “…In recent years, significant advances have been made in the field of rare diseases (RDs). However, there is a large number of RDs without specific treatment…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper by Zozaya, N., Villaseca, J., Abdalla, F., Calleja, M. A., Díez-Martín, J. L., Estévez, J., García-Sanz, R., Martínez-López, J., Sierra, J., Vera, R., Hidalgo-Vega, A.

    Published in Clinical & translational oncology (01-06-2022)
    “…CAR-T cell therapy represents a therapeutic revolution in the prognosis and treatment of patients with certain types of hematological cancer. However, they…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Pet Toxin from Enteroaggregative Escherichia coli Produces Cellular Damage Associated with Fodrin Disruption by VILLASECA, Jorge M, NAVARRO-GARCIA, Fernando, MENDOZA-HERNANDEZ, Guillermo, NATARO, James P, CRAVIOTO, Alejandro, ESLAVA, Carlos

    Published in Infection and Immunity (01-10-2000)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Cardiorenal syndrome: classification, pathophysiology, diagnosis and management. Literature review by Chávez-Iñiguez, Jonathan S, Sánchez-Villaseca, Sergio J, García-Macías, Luz A

    Published in Archivos de cardiologia de Mexico (04-04-2022)
    “…The cardiorenal syndrome is a complex entity in which a primary heart dysfunction causes kidney injury (Types 1 and 2) and vice versa (Types 3 and 4), being…”
    Get more information
    Journal Article
  6. 6

    In Vitro Effects of a High-Molecular-Weight Heat-Labile Enterotoxin from Enteroaggregative Escherichia coli by Navarro-García, F, Eslava, C, Villaseca, J M, López-Revilla, R, Czeczulin, J R, Srinivas, S, Nataro, J P, Cravioto, A

    Published in Infection and Immunity (01-07-1998)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Síndrome cardiorrenal: clasificación, fisiopatología, diagnóstico y tratamiento. Una revisión de las publicaciones médicas by Chávez-Iñiguez, Jonathan S., Sánchez-Villaseca, Sergio J., García-Macías, Luz A.

    Published in Archivos de cardiología de México (01-04-2022)
    “…El síndrome cardiorrenal es una entidad compleja en la que la disfunción primaria cardíaca produce daño renal (tipos 1 y 2) y viceversa (tipos 3 y 4) y los…”
    Get full text
    Journal Article
  9. 9

    Enteroaggregative Escherichia coli an emergent pathogen with different virulence properties by Villaseca, J M, Hernández, U, Sainz-Espuñes, T R, Rosario, C, Eslava, C

    “…Enteroaggregative Escherichia coli (EAEC) is an emergent bacterial pathogen. The first studies in developing countries with EAEC strains, showed that this…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Survival to different acid challenges and outer membrane protein profiles of pathogenic Escherichia coli strains isolated from pozol, a Mexican typical maize fermented food by Sainz, Teresita, Pérez, Julia, Villaseca, Jorge, Hernández, Ulises, Eslava, Carlos, Mendoza, Guillermo, Wacher, Carmen

    Published in International journal of food microbiology (01-01-2005)
    “…In this study, the acid resistance and the changes in outer membrane protein (Omps) profiles of Escherichia coli strains isolated from pozol, an acid-fermented…”
    Get full text
    Journal Article
  14. 14

    Detection of dengue virus from mosquito cell cultures inoculated with human serum in the presence of actinomycin D by Ramos, C, Villaseca, J M, García, H, Hernández, D G, Ramos-Castañeda, J, Imbert, J L

    “…We report the use of cultures of mosquito cells (TRA-284) to detect dengue virus in serum from cases of dengue fever in the state of Puebla, México. Using the…”
    Get more information
    Journal Article
  15. 15

    Psoriasis and cyclosporine: an attempt at topical treatment by Gajardo, J, Villaseca, J

    Published in Revista medíca de Chile (01-12-1994)
    “…In eight patients with chronic and stable psoriasis, the usefulness of topical cyclosporine solution using 50% dimethylsulfoxide as a vehicle was assessed in a…”
    Get more information
    Journal Article
  16. 16

    Hemorrhagic fever and the dengue shock syndrome by Ramos, C, García, H, Villaseca, J M

    Published in Salud pública de México (01-01-1993)
    “…Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) are the severe and/or fatal clinical manifestations of dengue fever. Epidemics of DHF/DSS occur…”
    Get more information
    Journal Article
  17. 17

    Casar cheese: Production physicochemical and microbiological characteristics by Mas Mayoral, M, Gonzalez Crespo, J, Nieto Villaseca, MJ

    Published in Archivos de zootecnia (01-01-1991)
    “…Milk production of four Merino (entrefino) sheep flocks from Casar area (Caceres) has been studied. Cheese yield of cheesemaking and composition of milks and…”
    Get full text
    Journal Article